Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the…
Year: 2023
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Sofwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
– Record Quarterly Revenue of $13.8M – Full Year Revenue Grew 63% YoY to $35.6M – Over…
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that…
Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed
InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is…
Data on Potential Biomarker for Qualigen Therapeutics’ Lead Program QN-302 Published in Peer-Reviewed Journal Molecules
S100P Gene Expression May Be Marker of Anti-Tumor Activity in Pancreatic Cancer In Vivo Models…
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
The global hair restoration market is expected to reach $13.6 billion by 2028 LOS ANGELES, March 08,…
aTyr Pharma to Present at March Investor Conferences
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
Replimune to Present at Two Upcoming Investor Conferences
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
Panbela to Host Fourth Quarter and Year End 2022 Earnings Conference Call on March 16, 2023
MINNEAPOLIS, March 08, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology
March 20, 2023 at 11:00 AM ET PORTLAND, Maine, March 08, 2023 (GLOBE NEWSWIRE) —…
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
Topline Data Expected in 2Q 2023 SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2023…
Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
OV350 is the first reported compound that directly binds to and activates the KCC2 co-transporter,…
Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
FDA recommends additional revised primary symptom-based endpoints Revive to provide amended statistical analysis plan to…
Verizon continues to upgrade El Paso’s best network
Recent upgrades lead to testing results that show customers in El Paso have the best…
Verizon continues to upgrade Greenville’s best network
Recent upgrades lead to testing results that show customers in Greenville have the best experience…
Netsurion Strengthens Partnership with Deep Instinct for Managed Endpoint Security
FORT LAUDERDALE, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Netsurion, a leading provider of Managed…
Borqs Technologies Wins a Project to Develop a 5G Rugged Handheld Device
SANTA CLARA, Calif., March 08, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…
Flexera 2023 State of the Cloud Report
Economic uncertainty refocuses priorities and challenges on cloud costs, and AI experimentation is significant ITASCA,…
Open Source Software Leader the Eclipse Foundation Previews its Showcase at Embedded World 2023
Come see the Eclipse Foundation and Zettascale in Hall 4, Booth 4-554 BRUSSELS, Belgium, March…